1. Home
  2. CMCM vs MCRB Comparison

CMCM vs MCRB Comparison

Compare CMCM & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCM
  • MCRB
  • Stock Information
  • Founded
  • CMCM 2009
  • MCRB 2010
  • Country
  • CMCM China
  • MCRB United States
  • Employees
  • CMCM N/A
  • MCRB N/A
  • Industry
  • CMCM Computer Software: Prepackaged Software
  • MCRB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMCM Technology
  • MCRB Health Care
  • Exchange
  • CMCM Nasdaq
  • MCRB Nasdaq
  • Market Cap
  • CMCM 139.6M
  • MCRB 141.9M
  • IPO Year
  • CMCM 2014
  • MCRB 2015
  • Fundamental
  • Price
  • CMCM $5.75
  • MCRB $0.80
  • Analyst Decision
  • CMCM
  • MCRB Buy
  • Analyst Count
  • CMCM 0
  • MCRB 4
  • Target Price
  • CMCM N/A
  • MCRB $5.63
  • AVG Volume (30 Days)
  • CMCM 51.9K
  • MCRB 844.5K
  • Earning Date
  • CMCM 04-17-2025
  • MCRB 03-04-2025
  • Dividend Yield
  • CMCM N/A
  • MCRB N/A
  • EPS Growth
  • CMCM N/A
  • MCRB N/A
  • EPS
  • CMCM N/A
  • MCRB N/A
  • Revenue
  • CMCM $105,082,614.00
  • MCRB $126,325,000.00
  • Revenue This Year
  • CMCM $37.71
  • MCRB N/A
  • Revenue Next Year
  • CMCM $39.26
  • MCRB N/A
  • P/E Ratio
  • CMCM N/A
  • MCRB N/A
  • Revenue Growth
  • CMCM N/A
  • MCRB 12856.41
  • 52 Week Low
  • CMCM $2.12
  • MCRB $0.54
  • 52 Week High
  • CMCM $6.78
  • MCRB $1.53
  • Technical
  • Relative Strength Index (RSI)
  • CMCM 57.85
  • MCRB 46.38
  • Support Level
  • CMCM $5.47
  • MCRB $0.81
  • Resistance Level
  • CMCM $6.25
  • MCRB $0.84
  • Average True Range (ATR)
  • CMCM 0.49
  • MCRB 0.04
  • MACD
  • CMCM 0.10
  • MCRB 0.00
  • Stochastic Oscillator
  • CMCM 63.82
  • MCRB 45.58

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: